# Medical Properties Trust share price today (Medical Properties Trust, Inc., MPT)

> Medical Properties Trust, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. MPT · Real Estate · REIT - Healthcare Facilities · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/mpt

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $2.02 (−60.9% in a year)
- P/E: 4.9×, over 1 year
- Revenue (Jun 2026): $271 M (+1.9% on a year ago)
- Profit (Jun 2026): −$2.3 M
- Operating margin: 57.4% (−3.5 points on a year ago)
- ROE: −6%, FY25
- ROIC: 4.6%, against a 5.7% cost of capital: −1.1 points
- Profit that came in as cash: 100%, last 2 years

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Medical Properties Trust share price today? Medical Properties Trust, Inc.'s share price was $2.02 at the close on 3 November 2026. It has been falling for 7 weeks. That is 55.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between $2 and $6, and at that close it was at the low of that range. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 35 weeks running. Over the last 10 years the share price moved −87% while the S&P 500 moved +255%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 6 March 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Medical Properties Trust pay? Medical Properties Trust, Inc. paid $0.35 per share over the last four reported quarters. The most recent declaration was $0.09 for Jun 2026. At today's price of $2.02 that is a yield of 17.33%, based on dividends already paid, not a forecast. ## Which stock lists is Medical Properties Trust on? Medical Properties Trust is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Medical Properties Trust profitable? Medical Properties Trust, Inc. posted a net loss of $2.3 M in the Jun 2026 quarter. The full FY25 year was a loss of $278 M. That loss is 0.8% of the quarter's revenue. The same quarter a year earlier lost $98.1 M. 9 of the last 12 reported quarters were loss-making. ## How much revenue does Medical Properties Trust make, and is it growing? Medical Properties Trust, Inc. reported $271 M of revenue in the Jun 2026 quarter, +1.9% on the same quarter a year earlier. That is the 4th quarter in a row with growth on the year before. Over 4 years it has grown −9.2% a year on average. The last full year, FY25, came in at $1.1 B. The last four reported quarters add to $1.1 B. FY25 revenue was $1.1 B, +2.9% on the year before. Recent pace: the last four quarters grew +12.4% on average, against −9.2% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +12.1%, against +22.9% a year over the last 8 quarters (rolling over). ## How much of every $100 of sales does Medical Properties Trust keep? Medical Properties Trust, Inc.'s operating margin was 57.4% in the Jun 2026 quarter, 3.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between 6.5% and 67.8%. The latest quarter is within that range. Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason. ## Is Medical Properties Trust's profit turning into cash? Over the last 2 years, 100% of Medical Properties Trust, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $231 M of operating cash against −$278 M of profit. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets. ## Where does Medical Properties Trust's cash go? Medical Properties Trust, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean. ## What is Medical Properties Trust's P/E ratio, and how does it compare with its own history? Medical Properties Trust, Inc.'s P/E is 4.9×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Medical Properties Trust business getting better or worse? Medical Properties Trust, Inc.'s business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 12 quarters of 2 measures, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Medical Properties Trust earn on its capital? Medical Properties Trust, Inc. earned a ROE of −6% in FY25. That is up from a low of −50% in FY24. Its return on capital used (ROIC) is 1.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −26.0% net margin and 0.07× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −26.0% net margin × 0.07× asset turnover × 3.26× leverage (assets divided by equity) ≈ −5.9% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: 4.6% − 5.7% = −1.1 percentage points. The 5.7% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Medical Properties Trust have too much debt? Medical Properties Trust, Inc. has total debt of $9.7 B against shareholder equity of $4.5 B as of Jun 2026, so its debt is 2.16× its equity. Year by year, that ratio went from 1.35 in FY21 to 2.12 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Medical Properties Trust shareholding pattern? 30.5% of Medical Properties Trust, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 11.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Medical Properties Trust from balance-sheet trouble? For Medical Properties Trust, Inc., the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Medical Properties Trust rank in its industry? 43.1 out of 100, rank 12 of 17 in REIT - Healthcare Facilities, with 69% of the evidence available. Medical Properties Trust, Inc. scores 43.1 out of 100 against the 17 companies it is compared with in REIT - Healthcare Facilities, ranking 12. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 22.3 + 12.2 + 8.6 + 0 = 43.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if ROA turns down or gross NPA rises while the share price lags its sector. ## Which companies is Medical Properties Trust compared with? Medical Properties Trust ranks 12 of 17 REIT - Healthcare Facilities companies on the 4-Factor Sector Score, with 43.1 out of 100. 1. [LTC Properties, Inc.](https://www.sectoralpha.in/us/stocks/ltc) LTC · leader · Most evidence points up · 80% evidence 74.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.8/35 · Income 61% · Profit 61.5% · 81% evidence Capital efficiency 15.9/25 · ROA 4.2% · ROE 8.5% · GNPA n/a · 68% evidence Valuation 12.3/20 · P/BV 1.47× · P/BV÷ROE 0.17 · 70% evidence Relative strength 20.0/20 · Lead over its industry 22.5% · Lead over S&P 500 12.2% · 1 year 27.6% · 100% evidence · 9 of 12 weeks ahead Exact sum: 25.8 + 15.9 + 12.3 + 20 = 74 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Omega Healthcare Investors, Inc.](https://www.sectoralpha.in/us/stocks/ohi) OHI · turning · Most evidence points up · 80% evidence 69.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Income 13.1% · Profit 84.7% · 81% evidence Capital efficiency 18.9/25 · ROA 5.1% · ROE 11.6% · GNPA n/a · 68% evidence Valuation 9.5/20 · P/BV 2.52× · P/BV÷ROE 0.22 · 70% evidence Relative strength 14.2/20 · Lead over its industry 6.8% · Lead over S&P 500 -2.3% · 1 year 9.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 27.2 + 18.9 + 9.5 + 14.2 = 69.8 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 3. [Strawberry Fields REIT, Inc.](https://www.sectoralpha.in/us/stocks/strw) STRW · quiet · Evidence leans up · 80% evidence 64.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.8/35 · Income 19.4% · Profit 33.3% · 81% evidence Capital efficiency 20.0/25 · ROA 6.3% · ROE 74.9% · GNPA n/a · 68% evidence Valuation 15.0/20 · P/BV 5.66× · P/BV÷ROE 0.08 · 70% evidence Relative strength 6.9/20 · Lead over its industry -0.9% · Lead over S&P 500 -9.3% · 1 year 7.6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.8 + 20 + 15 + 6.9 = 64.7 · What this means: Earnings are strong; relative strength in its sector is -0.9% and the one-year return is 7.6%. 4. [Welltower Inc.](https://www.sectoralpha.in/us/stocks/well) WELL · turning · Evidence leans up · 80% evidence 61.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.6/35 · Income 37.6% · Profit 37.3% · 81% evidence Capital efficiency 12.9/25 · ROA 2.2% · ROE 6.8% · GNPA n/a · 68% evidence Valuation 5.0/20 · P/BV 3.36× · P/BV÷ROE 0.49 · 70% evidence Relative strength 18.4/20 · Lead over its industry 17.2% · Lead over S&P 500 7.3% · 1 year 26.8% · 100% evidence · 5 of 12 weeks ahead Exact sum: 25.6 + 12.9 + 5 + 18.4 = 61.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Healthpeak Properties, Inc.](https://www.sectoralpha.in/us/stocks/doc) DOC · quiet · Evidence leans up · 80% evidence 55.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.9/35 · Income 5.5% · Profit 42.5% · 81% evidence Capital efficiency 11.4/25 · ROA 1.1% · ROE 9.2% · GNPA n/a · 68% evidence Valuation 12.7/20 · P/BV 1.55× · P/BV÷ROE 0.17 · 70% evidence Relative strength 14.5/20 · Lead over its industry 8.8% · Lead over S&P 500 -0.4% · 1 year 9.8% · 100% evidence · 2 of 12 weeks ahead Exact sum: 16.9 + 11.4 + 12.7 + 14.5 = 55.5 · What this means: Relative strength against the index is -0.4%, and revenue and profit growth are weak. 6. [National Health Investors, Inc.](https://www.sectoralpha.in/us/stocks/nhi) NHI · basing · Evidence leans up · 80% evidence 53.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.5/35 · Income 23.7% · Profit 16.2% · 81% evidence Capital efficiency 18.0/25 · ROA 4.6% · ROE 10.3% · GNPA n/a · 68% evidence Valuation 9.0/20 · P/BV 2.33× · P/BV÷ROE 0.23 · 70% evidence Relative strength 6.5/20 · Lead over its industry -6.6% · Lead over S&P 500 -14.8% · 1 year -10.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.5 + 18 + 9 + 6.5 = 53 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [CareTrust REIT, Inc.](https://www.sectoralpha.in/us/stocks/ctre) CTRE · basing · Evidence leans up · 80% evidence 52.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.6/35 · Income 53.1% · Profit 62.6% · 81% evidence Capital efficiency 15.8/25 · ROA 4.5% · ROE 7.7% · GNPA n/a · 68% evidence Valuation 7.6/20 · P/BV 2.11× · P/BV÷ROE 0.27 · 70% evidence Relative strength 6.8/20 · Lead over its industry -0.9% · Lead over S&P 500 -9.4% · 1 year 1.5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.6 + 15.8 + 7.6 + 6.8 = 52.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [American Healthcare REIT, Inc.](https://www.sectoralpha.in/us/stocks/ahr) AHR · quiet · Evidence leans down · 69% evidence 48.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.7/35 · Income 16.9% · Profit n/a · 52% evidence Capital efficiency 10.1/25 · ROA 1.9% · ROE 2.8% · GNPA n/a · 68% evidence Valuation 3.8/20 · P/BV 2.69× · P/BV÷ROE 0.96 · 70% evidence Relative strength 16.8/20 · Lead over its industry 12.3% · Lead over S&P 500 2.8% · 1 year 11.1% · 100% evidence · 5 of 12 weeks ahead Exact sum: 17.7 + 10.1 + 3.8 + 16.8 = 48.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Healthcare Realty Trust Incorporated](https://www.sectoralpha.in/us/stocks/hr) HR · basing · Too little evidence to rank firmly · 57% evidence 48.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 17.6/35 · Income -6.1% · Profit n/a · 52% evidence Capital efficiency 5.5/25 · ROA 0.9% · ROE 0% · GNPA n/a · 68% evidence Valuation 9.8/20 · P/BV 1.64× · P/BV÷ROE n/a · 10% evidence Relative strength 15.3/20 · Lead over its industry 7.6% · Lead over S&P 500 -1.7% · 1 year 6% · 100% evidence · 0 of 12 weeks ahead Exact sum: 17.6 + 5.5 + 9.8 + 15.3 = 48.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 10. [Sabra Health Care REIT, Inc.](https://www.sectoralpha.in/us/stocks/sbra) SBRA · quiet · Evidence leans down · 80% evidence 46.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.5/35 · Income 17.7% · Profit -63.9% · 81% evidence Capital efficiency 13.2/25 · ROA 3.2% · ROE 5.8% · GNPA n/a · 68% evidence Valuation 6.8/20 · P/BV 1.79× · P/BV÷ROE 0.31 · 70% evidence Relative strength 14.3/20 · Lead over its industry 7% · Lead over S&P 500 -2.2% · 1 year 7.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 12.5 + 13.2 + 6.8 + 14.3 = 46.8 · What this means: Relative strength against the index is -2.2%, and revenue and profit growth are weak. 11. [Ventas, Inc.](https://www.sectoralpha.in/us/stocks/vtr) VTR · quiet · Evidence leans down · 80% evidence 46.1 out of 100 Growth Capital Valuation Relative
12. Medical Properties Trust, Inc. this page MPT · quiet · Evidence leans down · 69% evidence 43.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.3/35 · Income 12.1% · Profit n/a · 52% evidence Capital efficiency 12.2/25 · ROA 2.6% · ROE 2.9% · GNPA n/a · 68% evidence Valuation 8.6/20 · P/BV 0.61× · P/BV÷ROE 0.21 · 70% evidence Relative strength 0.0/20 · Lead over its industry -54.5% · Lead over S&P 500 -58.6% · 1 year -60.2% · 100% evidence · 0 of 12 weeks ahead Exact sum: 22.3 + 12.2 + 8.6 + 0 = 43.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 13. [Universal Health Realty Income Trust](https://www.sectoralpha.in/us/stocks/uht) UHT · basing · Evidence leans down · 80% evidence 42.3 out of 100 Growth Capital Valuation Relative
14. [Sila Realty Trust, Inc.](https://www.sectoralpha.in/us/stocks/sila) SILA · Too little evidence to rank firmly · 56% evidence 38.2 out of 100 Growth Capital Valuation Relative
15. [Community Healthcare Trust Incorporated](https://www.sectoralpha.in/us/stocks/chct) CHCT · basing · Evidence leans down · 69% evidence 36.6 out of 100 Growth Capital Valuation Relative
16. [Diversified Healthcare Trust](https://www.sectoralpha.in/us/stocks/dhc) DHC · quiet · Too little evidence to rank firmly · 57% evidence 35.7 out of 100 Growth Capital Valuation Relative
17. [Chiron Real Estate Inc.](https://www.sectoralpha.in/us/stocks/xrn) XRN · quiet · Most evidence points down · 69% evidence 29.6 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Jun 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [REIT - Healthcare Facilities](https://www.sectoralpha.in/us/sectors/reit-healthcare-facilities), all 17 compared on one page. ## Which companies are close to Medical Properties Trust in size? Medical Properties Trust is the 13th largest of 17 REIT - Healthcare Facilities companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: LTC Properties, Inc., Diversified Healthcare Trust and Sila Realty Trust, Inc. Just below it: Strawberry Fields REIT, Inc., Universal Health Realty Income Trust and Chiron Real Estate Inc. ### REIT - Healthcare Facilities companies close in size

1. [LTC Properties, Inc.](https://www.sectoralpha.in/us/stocks/ltc) $2.5 billion
2. [Diversified Healthcare Trust](https://www.sectoralpha.in/us/stocks/dhc) $1.8 billion
3. [Sila Realty Trust, Inc.](https://www.sectoralpha.in/us/stocks/sila) $1.7 billion
4. Medical Properties Trust, Inc. $1.2 billion
5. [Strawberry Fields REIT, Inc.](https://www.sectoralpha.in/us/stocks/strw) $701 million
6. [Universal Health Realty Income Trust](https://www.sectoralpha.in/us/stocks/uht) $530 million
7. [Chiron Real Estate Inc.](https://www.sectoralpha.in/us/stocks/xrn) $416 million

[All 17 REIT - Healthcare Facilities companies, largest first](https://www.sectoralpha.in/us/sectors/reit-healthcare-facilities#all-companies)

### Companies close in size in other industries

1. [UMH Properties, Inc.](https://www.sectoralpha.in/us/stocks/umh) $1.3 billion · REIT - Residential
2. [Taysha Gene Therapies, Inc.](https://www.sectoralpha.in/us/stocks/tsha) $1.3 billion · Biotechnology
3. Medical Properties Trust, Inc. $1.3 billion
4. [PagerDuty, Inc.](https://www.sectoralpha.in/us/stocks/pd) $1.3 billion · Software - Application
5. [Tandem Diabetes Care, Inc.](https://www.sectoralpha.in/us/stocks/tndm) $1.3 billion · Medical Devices

## What else do people ask about Medical Properties Trust? ### What were Medical Properties Trust's latest quarterly results? Medical Properties Trust, Inc. reported revenue of $271 M and a net loss of $2.3 M for the Jun 2026 quarter. Earnings per share were −$0.01. The operating margin was 57.4%, 3.5 percentage points lower than a year earlier (as of 3 November 2026). ### What is Medical Properties Trust's market cap? Medical Properties Trust, Inc.'s market capitalisation is $1.2 B at a stock price of $2.02. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Medical Properties Trust performing? Medical Properties Trust, Inc.'s share price has been falling for 7 weeks. Over the past 13 weeks it has done worse than the S&P 500, for 35 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Medical Properties Trust's stock price go up? This page does not forecast Medical Properties Trust, Inc.'s stock price. What it shows instead: the stock price is $2.02, and it has been falling for 7 weeks. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Does Medical Properties Trust have too much debt? Yes, Medical Properties Trust, Inc. has a lot of debt: its debt is 2.00× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Is Medical Properties Trust's profit real cash? Yes, over the last 2 years, 100% of Medical Properties Trust, Inc.'s reported profit came in as cash from operations. The latest year was lower at -83%, so the trend is worth watching. In FY25, operating cash was $231 M against reported profit of −$278 M. Most of that cash then goes into a mix of the daily operating cycle and new capacity. These are yearly figures (as of 3 November 2026). ### Where is Medical Properties Trust in its business cycle? Medical Properties Trust, Inc.'s FY25 operating margin was 59.6%, against a 5-year range of 6.5% to 67.8%: the middle of its own range, neither a peak nor a low. The latest quarter was 57.4%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Medical Properties Trust story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Medical Properties Trust a stock worth studying right now? What the numbers show: Medical Properties Trust, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.